...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Chinese Takeovers

Toinv

Your points are well taken - Hepa has laid a strong foundation - I have often wondered if there is a family or friendship connection between Dr Wong and Hepa - if I am not mistaken, Dr Wong resigned his BOD seat to devote himself full time to pursue R&D endeavors - recently, Shawn Lu of Hepa USA became a director after the Hepa PP. 

Last year the 2nd quarter Zenith financials and MD&A were released 3/23/17. I'm not sure if we will get any news but events are going to happen soon. Hepas RofFF on RVX expires 4/15/19. RVX MD&A should be out this week.

GLTA

Chicagoest

Share
New Message
Please login to post a reply